KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $577,000 | +23.0% | 3,206 | -29.1% | 0.02% | +33.3% |
| Q2 2017 | $469,000 | +29.9% | 4,521 | -1.6% | 0.02% | +38.5% |
| Q1 2017 | $361,000 | +65.6% | 4,594 | -5.4% | 0.01% | +44.4% |
| Q4 2016 | $218,000 | -31.9% | 4,857 | -15.2% | 0.01% | -25.0% |
| Q3 2016 | $320,000 | +11.9% | 5,728 | +0.3% | 0.01% | -14.3% |
| Q2 2016 | $286,000 | +52.9% | 5,712 | +40.0% | 0.01% | +55.6% |
| Q1 2016 | $187,000 | -31.8% | 4,080 | -8.3% | 0.01% | -30.8% |
| Q4 2015 | $274,000 | +10.9% | 4,451 | +0.4% | 0.01% | +8.3% |
| Q3 2015 | $247,000 | – | 4,434 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|